ADVI’s Lindsay Bealor Greenleaf spoke to AIS Health about the drug pricing provisions currently being considered in spending bill negotiations and how they would impact the payment & reimbursement of drugs. Read more
Read moreADVI Finds New CAR-T DRG 018 Used by 10 New Hospitals in FY 2021 and 11% Increase in Reimbursement. DOWNLOAD THE FULL ANALYSIS HERE
Read moreADVI’s Strategic Analytics and Value Economics (SAVES) team found that despite an increase in Part D enrollment in 2020, there was a 12% decrease in the number of Part D beneficiaries reaching catastrophic coverage. DOWNLOAD THE FULL ANALYSIS HERE
Read moreAfter additional guidance and threat of audit from CMS, ADVI re-examined hospital transparency data to find that most hospitals have not updated their pricing information. Download full analysis here
Read more